Rebif 44 MCG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FY2YR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,867
Award facts
- Contract value 100% obligated
- $10,866.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,866.94 to AmerisourceBergen Drug Corp for the supply of REBIF 44 MCG/0.5 ML syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance to be completed by April 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The delivery order represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026.
The underlying IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and specialized medical commodities across multiple therapeutic domains. This delivery order for REBIF, an interferon beta-1a medication used in treating multiple sclerosis, exemplifies the company's role in delivering critical specialty pharmaceuticals to Defense Health Agency customers and other government healthcare systems. AmerisourceBergen's consistent receipt of competitively awarded contracts across varying order values demonstrates its established capability to meet federal procurement requirements and maintain a reliable supply chain for essential medical products supporting military personnel and veterans.
Quick answers
Who was awarded contract SPE2DB25FY2YR?
SPE2DB25FY2YR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 8, 2025.
How much is contract SPE2DB25FY2YR worth?
The government has obligated $10,867 on SPE2DB25FY2YR.
Is contract SPE2DB25FY2YR an order under another contract?
Yes. SPE2DB25FY2YR is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY2YR competed?
The extent of competition for SPE2DB25FY2YR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award